# FDA Inspection 1101366 - Biomat USA, Inc. - August 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2692377f-edf2-44f5-beaa-ed3006a032dd
Source feed: FDA_Inspections

> FDA Inspection 1101366 for Biomat USA, Inc. on August 29, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101366
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-08-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 953266 - 2015-12-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2572bac8-7cbf-4434-af1a-2605e0f43858)
- [FDA Inspection 839544 - 2013-07-03](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b0acfe0c-d3f2-4b0d-a51f-66179d6e0854)
- [FDA Inspection 703149 - 2010-12-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/54e7098a-b5c8-429d-8cb3-0b5577c0e9df)

Company: https://www.keypedia.com/companies/biomat-usa-inc/dffc80c1-3c1f-4a32-84d8-fe933b77be68

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d